‹ ›
MYP_003854
← PREVIOUS NEXT → BACK
Basic Information
Sequenece No:69
Antimicrobial
Antiviral
Antiviral ▸ Anti-HIV
Antiviral ▸ Anti-Pneumovirus ▸ Anti-RSV
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition ▸ Entry inhibitor
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition ▸ Fusion inhibitor
Standard
35 amino acids
C187H294N46O62S
Standard
Sequence
KVDFLEENITALLEEAQIQQEKNMYELQKLNSWDV
Physicochemical Analysis
4210.67 Da
4.17
-5.22
-5.45
-0.1493
-0.66
0.41
-0.07
54.53
100.29
0.0857
6990.00
6990.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1807.29
-14.19
58.0
58.0
148.0
296.0
4.0
41.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0009371 VERIFIED: YES
Provenance & Taxonomy
Simian immunodeficiency virus [Virus]
Virus-derived peptide
11723;0
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Entry inhibitor Fusion inhibitor
Simian immunodeficiency virus (gp160)
Cell-fusion assay
PaperFusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids | Dani Paul Bolognesi, Thomas James Matthews, Carl T. Wild, Durham, Shawn O'Lin Barney, Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois | Duke University, Durham, NC (US) | Patent:US7122190 Evidence URLhttps://patents.google.com/patent/US7122190/en PatentUS7122190
RECORD: Rec_0024664 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
HIV gp41 fusion inhibitor
32630.0
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Antiviral Anti-HIV
Simian immunodeficiency virus
PaperLong-lasting antiviral fusion inhibitor peptide conjugates comprising albumin and human immunodeficiency virus (HIV) peptides Evidence URLhttps://patents.google.com/patent/US7582301B1/en PatentUS 7582301 B1
RECORD: Rec_0073175 VERIFIED: NO
Provenance & Taxonomy
synthetic construct [Synthetic]
Respiratory syncytial virus fusion-inhibitory peptide
32630.0
Structure & Mods
synthetic linear peptide [Linear]
mixed L/D amino-acid peptide [Mixed]
Bio-Activity Profile
Antiviral Anti-RSV Fusion inhibitor
Simian immunodeficiency virus
PaperHuman respiratory syncytial virus peptides with antifusogenic and antiviral activities Evidence URLhttps://patents.google.com/patent/US6228983B1/en PatentUS 6228983 B1
RECORD: Rec_0090711 VERIFIED: YES
Provenance & Taxonomy
Human immunodeficiency virus 1 [Virus]
11676
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antiviral Fusion inhibitor
CEM
Qualitative inhibition
PaperMethods and compositions for treatment of HIV-1 infection using antiviral compounds in simultaneous or sequential combinations PatentUS6861059
RECORD: Rec_0261747 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Bio-Activity Profile
Antimicrobial Antiviral
Evidence URLhttps://patents.google.com/patent/US6228983B1/en PatentUS 6228983 B1
1 2 NEXT LAST
Showing 5 records on this page · Page 1 of 2